Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 37,317 shares at $139.90 ($5.2M) on 2016-11-04, disclosed to the SEC on 2016-11-07.
Seasonal sale ($5.2M) by Director — this insider has traded ALXN in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $136.00 | 100 | $14K | 0.3% |
| 2 | $137.77 | 2,600 | $358K | 6.8% |
| 3 | $139.05 | 9,020 | $1.3M | 23.9% |
| 4 | $139.90 | 334 | $47K | 0.9% |
| 5 | $139.98 | 11,838 | $1.7M | 31.6% |
| 6 | $140.83 | 8,521 |
| $1.2M |
| 22.9% |
| 7 | $141.84 | 831 | $118K | 2.3% |
| 8 | $144.90 | 334 | $48K | 0.9% |
| 9 | $145.06 | 3,739 | $542K | 10.4% |
| Total | $140.38 avg | 37,317 | $5.2M | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |